---
figid: PMC8620891__pharmaceuticals-14-01105-g001
figtitle: Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R
  Pathways in Acute Myeloid Leukemia
organisms:
- NA
pmcid: PMC8620891
filename: pharmaceuticals-14-01105-g001.jpg
figlink: /pmc/articles/PMC8620891/figure/pharmaceuticals-14-01105-f001/
number: F1
caption: PD-1–PD-L1/2 pathway mechanism in cancer and under physiologic conditions.
papertitle: The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R
  Pathways in Acute Myeloid Leukemia.
reftext: Laura Jimbu, et al. Pharmaceuticals (Basel). 2021 Nov;14(11):1105.
year: '2021'
doi: 10.3390/ph14111105
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI
keywords: PD-1 | PD-L1 | IL-10 | acute myeloid leukemia | cancer
automl_pathway: 0.9528522
figid_alias: PMC8620891__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC8620891__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8620891__pharmaceuticals-14-01105-g001.html
  '@type': Dataset
  description: PD-1–PD-L1/2 pathway mechanism in cancer and under physiologic conditions.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mhc
  - zip
  - cd
  - Tcr
  - Myo61F
---
